News

Vera Therapeutics Inc. (NASDAQ:VERA) is one of the best high short interest stocks with huge upside potential. Earlier in ...
Travere Therapeutics, Inc. (NASDAQ:TVTX) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On ...
Armistice Capital holds 8.9M shares in Travere Therapeutics as rare kidney disease stock climbs 110% following FILSPARI's ...
The global IgA nephropathy market is in growth due to rising awareness, better diagnostics, and advanced treatments like complement inhibitors. North. Tuesday, 02 January 2024 12:17 GMT.
IgA nephropathy (IgAN) is characterized by the deposition of IgA1-containing immune complexes in the glomerular mesangium. The pathogenesis follows a 4-hit cascade: 4-Hit Cascade.
The global IgA nephropathy market is anticipated to witness steady growth from 2025 to 2035, driven by the growing incidence of chronic kidney diseases and the introduction of innovative, ...
The global IgA nephropathy market is in growth due to rising awareness, better diagnostics, and advanced treatments like complement inhibitors. North America leads the market, supported by ...